Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Lantheus Announces Retirement of Michael P. Duffy, Senior Vice President and General Counsel
Lantheus Announces Retirement of Michael P. Duffy, Senior Vice President and General Counsel


Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions

Quidel Supports New NIH, CDC Public Health Initiative for At-home COVID-19 Testing
Quidel Supports New NIH, CDC Public Health Initiative for At-home COVID-19 Testing


Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it is

Quidel’s QuickVue® At-Home OTC COVID-19 Test Receives Emergency Use Authorization for Screening Use With Serial Testing
Quidel’s QuickVue® At-Home OTC COVID-19 Test Receives Emergency Use Authorization for Screening Use With Serial Testing


Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has

NanoString's GeoMx Digital Spatial Profiler Reveals Insights into COVID-19 in Two New Nature Publications: https://mms.businesswire.com/media/20191104005218/en/753909/5/NSTG-Logo-19-%28002%29.jpg
NanoString's GeoMx Digital Spatial Profiler Reveals Insights into COVID-19 in Two New Nature Publications


NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced that two peer-reviewed publications using the GeoMx®

Illumina Committed to Pursuing GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test
Illumina Committed to Pursuing GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test


Illumina, Inc. (NASDAQ: ILMN), today announced that it disagrees with, and will oppose, the U.S. Federal Trade Commission (FTC)’s challenge to its previously announced acquisition of GRAIL, a

Humana Healthy Horizons Partners with GoNoodle® to Boost Physical and Mental Health for 2.4 Million Kids : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Humana Healthy Horizons Partners with GoNoodle® to Boost Physical and Mental Health for 2.4 Million Kids


Humana Healthy Horizons, the Medicaid business of leading health and well-being company Humana Inc. (NYSE: HUM), announced a partnership with GoNoodle®, an interactive mindfulness and physical

Acadia Healthcare Forms Joint Venture with Geisinger to Build Two State-of-the-Art Behavioral Health Facilities in Northeastern and Central Pennsylvania: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Acadia Healthcare Forms Joint Venture with Geisinger to Build Two State-of-the-Art Behavioral Health Facilities in Northeastern and Central Pennsylvania


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it has formed a joint venture with Geisinger Health, one of Pennsylvania’s premier, integrated healthcare systems. The new

Lantheus Acquires Rights to Innovative Imaging Biomarker Targeting Fibroblast Activation Protein (FAP) from Noria
Lantheus Acquires Rights to Innovative Imaging Biomarker Targeting Fibroblast Activation Protein (FAP) from Noria


Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions

Agilent Awards Octagon Therapeutics with a Golden Ticket at LabCentral
Agilent Awards Octagon Therapeutics with a Golden Ticket at LabCentral


Agilent Technologies Inc. (NYSE: A) announces that Octagon Therapeutics has been awarded an Agilent Golden Ticket at LabCentral. The Golden Ticket was presented to Octagon during a virtual online

Simulations Plus Sets Date for Second Quarter Fiscal Year 2021 Earnings Release and Conference Call: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus Sets Date for Second Quarter Fiscal Year 2021 Earnings Release and Conference Call


Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report its financial results for the second quarter of fiscal year 2021, the period ended February 28, 2021, after the close of

TFS HealthScience standardisiert Arbeit mit Veeva Vault Clinical Operations Suite, um klinische Entwicklung zu beschleunigen
TFS HealthScience standardisiert Arbeit mit Veeva Vault Clinical Operations Suite, um klinische Entwicklung zu beschleunigen


Veeva Systems (NYSE: VEEV) hat heute bekanntgegeben, dass sich TFS HealthScience für die Veeva Vault Clinical Operations Suite entschieden hat, um das End-to-End-Management von Studien auf einer

Acadia Healthcare Forms Joint Venture with Lutheran Health Network of Indiana, LLC to Build Modern Behavioral Health Facility to Serve Fort Wayne Area Communities: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Acadia Healthcare Forms Joint Venture with Lutheran Health Network of Indiana, LLC to Build Modern Behavioral Health Facility to Serve Fort Wayne Area Communities


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it has formed a joint venture with Lutheran Health Network of Indiana, LLC, one of Indiana’s premier, integrated healthcare

TFS HealthScience Standardizes on Veeva Vault Clinical Operations Suite to Accelerate Clinical Development
TFS HealthScience Standardizes on Veeva Vault Clinical Operations Suite to Accelerate Clinical Development


Veeva Systems (NYSE: VEEV) today announced that TFS HealthScience selected Veeva Vault Clinical Operations Suite for end-to-end study management on a single cloud platform. The global CRO is taking

TFS HealthScience Standardizes on Veeva Vault Clinical Operations Suite to Accelerate Clinical Development
TFS HealthScience Standardizes on Veeva Vault Clinical Operations Suite to Accelerate Clinical Development


Veeva Systems (NYSE: VEEV) today announced that TFS HealthScience selected Veeva Vault Clinical Operations Suite for end-to-end study management on a single cloud platform. The global CRO is taking

Boehringer Ingelheim vollzieht mit Veeva CRM Engage Meeting einen schnellen Übergang zur digitalen Interaktion
Boehringer Ingelheim vollzieht mit Veeva CRM Engage Meeting einen schnellen Übergang zur digitalen Interaktion


Boehringer Ingelheim, ein globales Top-20-Pharmaunternehmen, setzt standardmäßig auf Veeva CRM Engage Meeting, um die Interaktionen zwischen seiner globalen Außendienstorganisation und

The Humana Foundation Awards Nearly $1 Million in a Second Year Investment to Kingsley House and Growing Local Food Collaborative : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
The Humana Foundation Awards Nearly $1 Million in a Second Year Investment to Kingsley House and Growing Local Food Collaborative


The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM) for the past 40 years, announces its second year of investments, totaling nearly $1 million in two local projects in the greater

Epic and Humana Deliver on Commitment to Enhance Connectivity and Collaboration Among Patients, Providers, and Health Plans: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Epic and Humana Deliver on Commitment to Enhance Connectivity and Collaboration Among Patients, Providers, and Health Plans


Humana Inc. (NYSE: HUM), a leading health and well-being company, and Epic, developer of the nation’s most widely used comprehensive health record, have completed the first stage of a joint effort

Boehringer Ingelheim Makes Rapid Shift to Digital Engagement with Veeva CRM Engage Meeting
Boehringer Ingelheim Makes Rapid Shift to Digital Engagement with Veeva CRM Engage Meeting


Boehringer Ingelheim, a top 20 global pharmaceutical company, is standardizing on Veeva CRM Engage Meeting to drive more valued interactions between its global field organization and healthcare

Boehringer Ingelheim Makes Rapid Shift to Digital Engagement with Veeva CRM Engage Meeting
Boehringer Ingelheim Makes Rapid Shift to Digital Engagement with Veeva CRM Engage Meeting


Boehringer Ingelheim, a top 20 global pharmaceutical company, is standardizing on Veeva CRM Engage Meeting to drive more valued interactions between its global field organization and healthcare

Humana Adds H Mart to List of National Retailers for Healthy Foods Card Benefit: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Humana Adds H Mart to List of National Retailers for Healthy Foods Card Benefit


Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies and H Mart, the largest Asian supermarket chain in the U.S., announced today a collaboration to combat food

Dexcom Promotes Jereme Sylvain to Chief Financial Officer: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Promotes Jereme Sylvain to Chief Financial Officer


DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring, today announced the promotion of Jereme Sylvain to the role of Executive Vice President and Chief

Lantheus Announces Presentation Featuring AZEDRA® (iobenguane I 131) at ENDO 2021
Lantheus Announces Presentation Featuring AZEDRA® (iobenguane I 131) at ENDO 2021


Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions

Quidel Corporation Applauds Biden Administration Plan to Expand COVID-19 Testing
Quidel Corporation Applauds Biden Administration Plan to Expand COVID-19 Testing


Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, today announced its support for the

Illumina Announces Board Changes
Illumina Announces Board Changes


Illumina, Inc. (NASDAQ: ILMN) (the “Company”) today announced that Jay Flatley has decided to step down from the Board of Directors and John W. Thompson will be appointed as the Company’s new Chair

Waters Peptide Multi-Attribute Method for BioAccord System Boosts Innovator and Biosimilar Drug Development and Commercialization
Waters Peptide Multi-Attribute Method for BioAccord System Boosts Innovator and Biosimilar Drug Development and Commercialization


Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC